Annual Working Capital
-$28.31 M
-$19.85 M-234.75%
June 30, 2024
Summary
- As of February 7, 2025, RENB annual working capital is -$28.31 million, with the most recent change of -$19.85 million (-234.75%) on June 30, 2024.
- During the last 3 years, RENB annual working capital has fallen by -$47.33 million (-248.91%).
- RENB annual working capital is now -248.91% below its all-time high of $19.01 million, reached on June 1, 2021.
Performance
RENB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$21.09 M
+$7.23 M+25.52%
September 30, 2024
Summary
- As of February 7, 2025, RENB quarterly working capital is -$21.09 million, with the most recent change of +$7.23 million (+25.52%) on September 30, 2024.
- Over the past year, RENB quarterly working capital has dropped by -$12.90 million (-157.49%).
- RENB quarterly working capital is now -210.91% below its all-time high of $19.01 million, reached on June 1, 2021.
Performance
RENB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RENB Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -234.8% | -157.5% |
| 3 y3 years | -248.9% | -157.5% |
| 5 y5 years | -348.7% | -157.5% |
RENB Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -248.9% | at low | -350.6% | +25.5% |
| 5 y | 5-year | -248.9% | at low | -210.9% | +25.5% |
| alltime | all time | -248.9% | at low | -210.9% | +25.5% |
Renovaro Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$21.09 M(-25.5%) |
| Jun 2024 | -$28.31 M(+234.8%) | -$28.31 M(+44.1%) |
| Mar 2024 | - | -$19.65 M(+73.1%) |
| Dec 2023 | - | -$11.36 M(+38.7%) |
| Sep 2023 | - | -$8.19 M(-3.2%) |
| Jun 2023 | -$8.46 M(-371.6%) | - |
| Jun 2023 | - | -$8.46 M(+7.8%) |
| Mar 2023 | - | -$7.85 M(+32.9%) |
| Dec 2022 | - | -$5.90 M(-706.4%) |
| Sep 2022 | - | $973.40 K(-68.7%) |
| Jun 2022 | $3.11 M(-83.6%) | $3.11 M(-25.6%) |
| Mar 2022 | - | $4.18 M(-50.3%) |
| Dec 2021 | - | $8.42 M(-40.9%) |
| Sep 2021 | - | $14.24 M(-25.1%) |
| Jun 2021 | $19.01 M(+150.0%) | $19.01 M(+441.2%) |
| Mar 2021 | - | $3.51 M(+43.4%) |
| Dec 2020 | - | $2.45 M(-53.2%) |
| Sep 2020 | - | $5.23 M(-31.2%) |
| Jun 2020 | $7.61 M(-33.2%) | $7.61 M(-26.1%) |
| Mar 2020 | - | $10.29 M(+29.1%) |
| Dec 2019 | - | $7.97 M(-19.5%) |
| Sep 2019 | - | $9.91 M(-13.0%) |
| Jun 2019 | $11.38 M(-23.5%) | $11.38 M(+26.7%) |
| Mar 2019 | - | $8.99 M(-22.7%) |
| Dec 2018 | - | $11.63 M(-8.9%) |
| Sep 2018 | - | $12.76 M(-14.3%) |
| Jun 2018 | $14.89 M | $14.89 M(-7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $16.16 M(+1179.0%) |
| Dec 2017 | - | $1.26 M(-42.8%) |
| Sep 2017 | - | $2.21 M(+82.7%) |
| Jun 2017 | $1.21 M(-255.9%) | $1.21 M(-169.0%) |
| Mar 2017 | - | -$1.75 M(+56.0%) |
| Dec 2016 | - | -$1.12 M(+79.7%) |
| Sep 2016 | - | -$625.50 K(-19.4%) |
| Jun 2016 | -$775.80 K(-185.2%) | -$775.80 K(+271.6%) |
| Mar 2016 | - | -$208.80 K(-169.9%) |
| Dec 2015 | - | $298.80 K(-46.1%) |
| Sep 2015 | - | $554.20 K(-77.9%) |
| Jun 2015 | $910.60 K(-72.3%) | - |
| Mar 2015 | - | $2.50 M(-23.9%) |
| Dec 2014 | $3.29 M(-6523.0%) | $3.29 M(-227.1%) |
| Sep 2014 | - | -$2.59 M(-11.6%) |
| Jun 2014 | - | -$2.93 M(+15.3%) |
| Mar 2014 | - | -$2.54 M(+3100.3%) |
| Dec 2013 | - | -$79.30 K(+12.3%) |
| Sep 2013 | - | -$70.60 K(+30.3%) |
| Jun 2013 | - | -$54.20 K(+5.9%) |
| Mar 2013 | -$51.20 K(+276.5%) | -$51.20 K(+23.4%) |
| Dec 2012 | - | -$41.50 K(+30.5%) |
| Sep 2012 | - | -$31.80 K(+29.3%) |
| Jun 2012 | - | -$24.60 K(+80.9%) |
| Mar 2012 | -$13.60 K(+56.3%) | -$13.60 K(+46.2%) |
| Dec 2011 | - | -$9300.00 |
| Mar 2011 | -$8700.00 | - |
FAQ
- What is Renovaro Biosciences annual working capital?
- What is the all time high annual working capital for Renovaro Biosciences?
- What is Renovaro Biosciences annual working capital year-on-year change?
- What is Renovaro Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly working capital year-on-year change?
What is Renovaro Biosciences annual working capital?
The current annual working capital of RENB is -$28.31 M
What is the all time high annual working capital for Renovaro Biosciences?
Renovaro Biosciences all-time high annual working capital is $19.01 M
What is Renovaro Biosciences annual working capital year-on-year change?
Over the past year, RENB annual working capital has changed by -$19.85 M (-234.75%)
What is Renovaro Biosciences quarterly working capital?
The current quarterly working capital of RENB is -$21.09 M
What is the all time high quarterly working capital for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly working capital is $19.01 M
What is Renovaro Biosciences quarterly working capital year-on-year change?
Over the past year, RENB quarterly working capital has changed by -$12.90 M (-157.49%)